183 related articles for article (PubMed ID: 30902074)
1. Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts.
Mendieta I; Nuñez-Anita RE; Nava-Villalba M; Zambrano-Estrada X; Delgado-González E; Anguiano B; Aceves C
BMC Cancer; 2019 Mar; 19(1):261. PubMed ID: 30902074
[TBL] [Abstract][Full Text] [Related]
2. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
[TBL] [Abstract][Full Text] [Related]
3. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
Zambrano-Estrada X; Landaverde-Quiroz B; Dueñas-Bocanegra AA; De Paz-Campos MA; Hernández-Alberto G; Solorio-Perusquia B; Trejo-Mandujano M; Pérez-Guerrero L; Delgado-González E; Anguiano B; Aceves C
BMC Vet Res; 2018 Mar; 14(1):87. PubMed ID: 29530037
[TBL] [Abstract][Full Text] [Related]
4. 1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.
Su Y; Vanderlaag K; Ireland C; Ortiz J; Grage H; Safe S; Frankel AE
Breast Cancer Res; 2007; 9(4):R56. PubMed ID: 17764562
[TBL] [Abstract][Full Text] [Related]
5. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
6. Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models.
Álvarez-León W; Mendieta I; Delgado-González E; Anguiano B; Aceves C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445656
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR).
Aceves C; García-Solís P; Arroyo-Helguera O; Vega-Riveroll L; Delgado G; Anguiano B
Mol Cancer; 2009 Jun; 8():33. PubMed ID: 19500378
[TBL] [Abstract][Full Text] [Related]
8. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway.
Jin H; Lee WS; Eun SY; Jung JH; Park HS; Kim G; Choi YH; Ryu CH; Jung JM; Hong SC; Shin SC; Kim HJ
Int J Oncol; 2014 Oct; 45(4):1629-37. PubMed ID: 24993541
[TBL] [Abstract][Full Text] [Related]
9. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
10. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
11. Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection.
Alfaro Y; Delgado G; Cárabez A; Anguiano B; Aceves C
Mol Cancer; 2013 May; 12():45. PubMed ID: 23705792
[TBL] [Abstract][Full Text] [Related]
12. A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer.
Nuñez-Anita RE; Arroyo-Helguera O; Cajero-Juárez M; López-Bojorquez L; Aceves C
Prostaglandins Other Lipid Mediat; 2009 Jun; 89(1-2):34-42. PubMed ID: 19443248
[TBL] [Abstract][Full Text] [Related]
13. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
14. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
Go RE; Kim CW; Jeon SY; Byun YS; Jeung EB; Nam KH; Choi KC
Environ Toxicol; 2017 Apr; 32(4):1439-1454. PubMed ID: 27539251
[TBL] [Abstract][Full Text] [Related]
15. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
[TBL] [Abstract][Full Text] [Related]
16. DHEA increases epithelial markers and decreases mesenchymal proteins in breast cancer cells and reduces xenograft growth.
Colín-Val Z; González-Puertos VY; Mendoza-Milla C; Gómez EO; Huesca-Gómez C; López-Marure R
Toxicol Appl Pharmacol; 2017 Oct; 333():26-34. PubMed ID: 28803991
[TBL] [Abstract][Full Text] [Related]
17. Shock Wave Application Increases the Antineoplastic Effect of Molecular Iodine Supplement in Breast Cancer Xenografts.
Peña M; Delgado-Gonzalez E; López-Marín LM; Millán-Chiu BE; Fernández F; Rodriguez-Castelan J; Muñoz-Torres C; Carrasco G; Anguiano B; Loske AM; Aceves C
Ultrasound Med Biol; 2020 Mar; 46(3):649-659. PubMed ID: 31883734
[TBL] [Abstract][Full Text] [Related]
18. 6-iodolactone, key mediator of antitumoral properties of iodine.
Nava-Villalba M; Aceves C
Prostaglandins Other Lipid Mediat; 2014 Aug; 112():27-33. PubMed ID: 25018052
[TBL] [Abstract][Full Text] [Related]
19. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
Liu J; Chen X; Ward T; Pegram M; Shen K
Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
[TBL] [Abstract][Full Text] [Related]
20. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
